Skip to main content
Equibles
USNA logo

USNA · Usana Health Sciences Inc · Metrics

Track USNA — free

Use USNA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research USNA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$14.07 +0.03 (+0.21%) At close · Oct 27 Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$262.92M
Shares
18.48M
Volume · Oct 27 136.81K Avg daily vol (3M) 205.85K

USNA metrics

106 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$14.07
Market cap
$262.92M

Price action

20 metrics
Price change (1W)
-4.4%
Price change (30D)
-5.1%
Price change (3M)
-39.5%
Price change (6M)
-27.9%
Price change (YTD)
-28.3%
Price change (1Y)
-30.0%
Trailing year
Price change (5Y)
-84.8%
52-week high
$23.24
52-week low
$12.86
Change from 52-week high
-39.5%
Change from 52-week low
+9.4%
Annualized volatility
53.6%
Annualized volatility (3M)
77.3%
Beta
0.9
RSI (14D)
41.0
Price vs SMA 50
-2.8%
Price vs SMA 200
-22.7%
Avg volume (3M)
205,853
Relative volume
0.7
Average dollar volume
$3.05M

Company

3 metrics
Sector
Consumer Defensive
Industry
Packaged Foods
Shares outstanding
18.48M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.1×
reciprocal yield 967.9%
EV / EBITDA
3.0×
reciprocal yield 33.2%
EV / EBIT
—
P / sales
0.3×
reciprocal yield 347.4%
P / book
0.5
reciprocal yield 200.2%
FCF yield
6.1%
TTM · current market cap
Buyback yield
0.0%
P / FCF
16.5
reciprocal yield 6.1%
P / operating cash flow
9.5
reciprocal yield 10.5%
Earnings yield
-8.4%

Historical valuation

8 metrics
P / E historical average (3Y)
16.1×
reciprocal yield 6.2%
P / E historical average (5Y)
15.7×
reciprocal yield 6.4%
EV / revenue historical average (3Y)
0.3×
reciprocal yield 333.3%
EV / revenue historical average (5Y)
0.3×
reciprocal yield 333.3%
EV / EBIT historical average (3Y)
5.9×
reciprocal yield 17.1%
EV / EBIT historical average (5Y)
5.9×
reciprocal yield 17.1%
EV / EBITDA historical average (3Y)
3.4×
reciprocal yield 29.2%
EV / EBITDA historical average (5Y)
3.4×
reciprocal yield 29.2%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-04
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
77.4%
Operating margin
-0.1%
Trailing 12 months
Net margin
-2.4%
Gross profit (TTM)
$707.36M
Operating profit (TTM)
−$1.08M
Net income (TTM)
−$22.16M
Trailing 12 months
Diluted EPS (TTM)
$-1.18
FCF margin
1.7%
Effective tax rate
1,253.4%

Per share

11 metrics
Revenue per diluted share (TTM)
$49.65
Gross profit per diluted share (TTM)
$38.45
Operating profit per diluted share (TTM)
$-0.05
EBITDA per diluted share (TTM)
$1.71
Net income per diluted share (TTM)
$-1.20
Operating cash flow per diluted share (TTM)
$1.50
Free cash flow per diluted share (TTM)
$0.86
Capital expenditures per diluted share (TTM)
$0.64
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.77
Book value per share
$29.16

Growth

11 metrics
Revenue growth YoY
-5.3%
Year over year
Net income growth YoY
-321.5%
Revenue (TTM)
$913.36M
Trailing 12 months
EPS growth YoY
-323.1%
Shares change YoY
-0.3%
Year over year · fewer shares
Revenue CAGR (3Y)
-2.5%
Revenue CAGR (5Y)
-4.0%
EPS CAGR (3Y)
-45.5%
EPS CAGR (5Y)
-37.0%
FCF CAGR (3Y)
-55.0%
FCF CAGR (5Y)
-43.3%

Quality

14 metrics
Return on equity
-4.2%
Return on assets
-3.2%
Debt / equity
0.0
Current ratio
2.7
EBITDA (TTM)
$31.35M
Free cash flow (TTM)
$15.93M
Quick ratio
1.8
Interest coverage
-2.6
Net debt / EBITDA
-5.4
Return on invested capital
—
Trailing 12 months
Net cash
$168.56M
Latest balance sheet
Cash & equivalents
$168.56M
Total assets
$703.21M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$27.73M
Capital expenditures (TTM)
$11.79M
R&D (TTM)
—
SG&A (TTM)
$334.60M
Stock compensation (TTM)
$14.18M
R&D / revenue
—
Stock compensation / revenue
1.6%

Ownership (13F)

9 metrics
13F filers
137
13F filer change QoQ
-2
Institutional ownership
61.8%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
31.9%
Private-fund adviser ownership
30.5%
Active holders' share change QoQ
+6.4%
Holder tenure
15.0
Price vs estimated holder cost
-40.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
10.4%

Short interest

3 metrics
Short interest
4.2%
Latest settlement · 4.4 days to cover
Days to cover
4.4d
Short-squeeze score
52 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 896264 CUSIP 90328M107 13F (30d) 19 filings 19 filers Visit website Investor relations